|
| 1. | 3. Carbamazepine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > F. Somatic Therapies for Children and Adolescents |
|
| 2. | 3. Carbamazepine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes |
|
| 3. | 4. Carbamazepine APA Practice Guidelines > TREATING BIPOLAR DISORDER: A Quick Reference Guide > C. Additional Information About Pharmacotherapeutic Agents |
|
| 4. | 4. Carbamazepine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > D. Maintenance Treatment |
|
| 5. | a) Anticonvulsants APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 2. Adjunctive medications |
|
| 6. | a) Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 3. Carbamazepine |
|
| 7. | b) Carbamazepine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > B. Somatic Treatments of Acute Depressive Episodes > 2. Anticonvulsants |
|
| 8. | b) Toxicity/overdose APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 3. Carbamazepine |
|
| 9. | c) Carbamazepine APA Practice Guidelines > Practice Guideline for the Treatment of Patients With HIV/AIDS > PART B: Review and Synthesis of Available Evidence > VI. Data Regarding Psychiatric Treatments for Individuals With HIV Infection > B. Pharmacologic Treatment > 4. Mood stabilizers |
|
| 10. | c) Implementation and dosing APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition > PART B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Somatic Treatments of Acute Manic and Mixed Episodes > 3. Carbamazepine |
|
| 11. | Carbamazepine has demonstrated efficacy for impulsivity, anger, suicidality, and anxiety in... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part A: Treatment Recommendations for Patients With Borderline Personality Disorder > II. Formulation and Implementation of a Treatment Plan > D. Specific Treatment Strategies for the Clinical Features of Borderline Personality Disorder > 2. Pharmacotherapy and other somatic treatments > a) Treatment of affective dysregulation symptoms |
|
| 12. | Carbamazepine's most common side effects include neurological symptoms (e.g., diplopia), blurred... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 4. Lithium carbonate and anticonvulsant mood stabilizers > c) Side effects |
|
| 13. | Side effects APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Schizophrenia Second Edition > Part B: Background Information and Review of Available Evidence > V. Review and Synthesis of Available Evidence > A. Pharmacological Treatments > 2. Adjunctive medications > a) Anticonvulsants |
|
| 14. | The anticonvulsant mood stabilizer carbamazepine has been studied in two double-blind, placebo-... APA Practice Guidelines > Practice Guideline for the Treatment of Patients With Borderline Personality Disorder > Part B: Background Information and Review of Available Evidence > VI. Review and Synthesis of Available Evidence > C. Review of Pharmacotherapy and Other Somatic Treatments > 4. Lithium carbonate and anticonvulsant mood stabilizers > b) Efficacy |
|
| 15. | TABLE 397. Commonly used mood stabilizers in pregnancy: summary points Textbook of Psychiatry > Chapter 39. Treatment of Women > Psychiatric Disorders in Pregnancy > Treatment of Bipolar Disorder During Pregnancy |
|
| 16. | Carbamazepine Textbook of Psychiatry > Chapter 36. Treatment of Children and Adolescents > Psychopharmacology > Mood-Stabilizing Agents |
|
| 17. | Carbamazepine Textbook of Psychiatry > Chapter 26. Psychopharmacology > Mood Stabilizers |
|
| 18. | Clinical Use Textbook of Psychiatry > Chapter 26. Psychopharmacology > Mood Stabilizers > Carbamazepine |
|
| 19. | Contraindications Textbook of Psychiatry > Chapter 26. Psychopharmacology > Mood Stabilizers > Carbamazepine |
|
| 20. | Drug Interactions Textbook of Psychiatry > Chapter 26. Psychopharmacology > Mood Stabilizers > Carbamazepine |
|